Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacira BiosciencesDicerna PharmaceuticalsInnovivaLigand PharmaceuticalsConstellation Pharmaceuticals
SymbolNASDAQ:PCRXNASDAQ:DRNANASDAQ:INVANASDAQ:LGNDNASDAQ:CNST
Price Information
Current Price$46.12$19.56$13.85$119.90$37.52
52 Week RangeBuyBuyN/ABuyBuy
Beat the Market™ Rank
Overall Score1.61.71.51.41.6
Analysis Score3.34.50.03.34.4
Community Score2.83.02.22.92.5
Dividend Score0.00.00.00.00.0
Ownership Score0.01.04.00.01.0
Earnings & Valuation Score1.90.01.30.60.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$54.50$34.20N/A$163.20$50.29
% Upside from Price Target18.17% upside74.85% upsideN/A36.11% upside34.02% upside
Trade Information
Market Cap$1.94 billion$1.52 billion$1.41 billion$1.89 billion$1.58 billion
Beta1.31.841.021.583.62
Average Volume603,968655,496719,196351,797591,302
Sales & Book Value
Annual Revenue$421.03 million$23.90 million$261.02 million$120.28 millionN/A
Price / Sales4.6160.505.3816.00N/A
Cashflow$1.73 per shareN/A$1.73 per share$6.08 per shareN/A
Price / Cash26.71N/A7.9919.73N/A
Book Value$8.51 per share$2.22 per share$3.38 per share$43.68 per share$8.23 per share
Price / Book5.428.814.102.74N/A
Profitability
Net Income$-11,020,000.00$-120,460,000.00$157.29 million$629.30 million$-85,550,000.00
EPS$0.86($1.76)$1.43$2.11($3.04)
Trailing P/E RatioN/AN/A8.10N/AN/A
Forward P/E Ratio23.90N/A11.5438.06N/A
P/E Growth$1.54N/AN/A$2.99N/A
Net Margins-0.02%-213.04%66.50%-55.63%N/A
Return on Equity (ROE)13.89%-74.79%59.11%3.68%-47.66%
Return on Assets (ROA)6.06%-22.53%26.69%2.03%-36.94%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.94%0.12%0.93%0.69%0.12%
Current Ratio5.37%2.90%166.87%40.65%18.75%
Quick Ratio4.63%2.90%166.87%40.29%18.75%
Ownership Information
Institutional Ownership PercentageN/A82.78%72.95%N/AN/A
Insider Ownership Percentage5.80%21.28%0.32%8.40%43.70%
Miscellaneous
Employees51878611682
Shares Outstanding42.12 million73.92 million101.32 million16.05 million41.84 million
Next Earnings Date8/13/2020 (Estimated)8/13/2020 (Estimated)7/22/2020 (Estimated)8/4/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.